Mode
Text Size
Log in / Sign up

Telenursing review shows reduced COPD and asthma exacerbations and hospitalizations

Telenursing review shows reduced COPD and asthma exacerbations and hospitalizations
Photo by Obi / Unsplash
Key Takeaway
Telenursing reduced COPD and asthma exacerbations and hospitalizations but did not shorten hospital stays.

A systematic review examined telenursing versus traditional nursing care for adults with COPD or asthma. The analysis included 4,340 patients, with 2,731 in the telenursing group and 1,609 in the comparison group. Follow-up occurred at six and twelve months, focusing on healthcare system impact.

Primary outcomes showed telenursing reduced exacerbation rates at six months (1.2 vs. 0.9) and significantly at twelve months (2.1 vs. 5.8). Hospital admissions decreased at both six months (0.65 vs. 0.8) and twelve months (0.7 vs. 1.25). ED presentations were similar at twelve months (1.2 in both groups).

Length of stay showed minimal differences: 5.2 vs. 5.7 days at six months and 9.1 vs. 9.2 days at twelve months. Secondary outcomes like treatment adherence, acceptability, and satisfaction were not consistently reported.

Limitations included lack of consistency across outcomes and need for standardized assessment methods. The review suggests telenursing may slightly unburden healthcare systems by reducing exacerbations and hospitalizations, but it did not shorten length of stay once patients required inpatient care.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Chronic respiratory diseases represent a major cause of morbidity/mortality and healthcare expenditure due to disease exacerbations, emergency department (ED) presentations, hospitalizations, and length of stay (LOS). This systematic review primarily aimed to evaluate the impact on the healthcare system of telenursing vs. traditional nursing care in the management of adults (≥18 years) with chronic respiratory diseases; secondarily, on treatment adherence, acceptability, and satisfaction. Electronic (PubMed, Scopus, Web of Science) and manual searches were performed until April 6, 2025, following PRISMA statement (PROSPERO CRD420251175395). Data were qualitatively synthesized; studies included were judged using dedicated tools. 39 studies including 4,340 patients (2,731 telenursing vs. 1,609 comparison), 3,231 with COPD and 888 with asthma, were included. Telenursing reduced exacerbation rates per patient: means 1.2 in telenursing vs. 0.9 in the comparison group at six months and 2.1 vs. 5.8 at twelve months. ED presentations remained similar (1.2 at twelve months in both groups). Hospital admissions were lower with telenursing (0.65 vs. 0.8 at six months; 0.7 vs. 1.25 at twelve months). LOS showed minimal differences (5.2 vs. 5.7 days at six months; 9.1 vs. 9.2 days at twelve months). Telenursing potentially slightly unburdens healthcare systems, reducing exacerbation and hospitalization rates, but did not shorten LOS once patients required inpatient care. This lack of consistency across all outcomes may suggest that telenursing may have a prevention/early detection role for clinical exacerbations, but may have limited influence on the clinical course once hospitalization becomes necessary. Further studies with standardized assessment methods are needed to evaluate treatment adherence, acceptability, and satisfaction. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251175395, PROSPERO CRD420251175395.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.